Literature DB >> 11725821

A behavioural pattern analysis of hypoglutamatergic mice--effects of four different antipsychotic agents.

M Nilsson1, S Waters, N Waters, A Carlsson, M L Carlsson.   

Abstract

In a hypoglutamatergic rodent model, we have observed certain behaviours that might have relevance for the cognitive impairments seen in autism and schizophrenia. Thus, hypoglutamatergic mice show defective habituation, impaired attention, a meagre behavioural repertoire and a general behavioural primitivization. The aim of the present study was to characterise and quantify changes in movement pattern in mice rendered hypoglutamatergic by means of MK-801 treatment, using an automated video tracking system. Further, the effects of four different antipsychotic drugs, the classical neuroleptic haloperidol, the atypical antipsychotic clozapine, the DA D2/5-HT2A antagonist risperidone and the selective 5-HT2A-receptor antagonist M100907, were compared with respect to effects on NMDA antagonist-induced movement pattern alterations. We found that each receptor antagonist had a unique effect on the MK-801-induced behavioural primitivization. Haloperidol was unable to affect the monotonous behaviour induced by MK-801, while risperidone, clozapine and M100907 produced movement patterns of high intricacy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11725821     DOI: 10.1007/s007020170008

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  14 in total

1.  Sex-dependent antipsychotic capacity of 17β-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males.

Authors:  Michal Arad; Ina Weiner
Journal:  Neuropsychopharmacology       Date:  2010-07-07       Impact factor: 7.853

2.  Activation of a nitric-oxide-sensitive cAMP pathway with phencyclidine: elevated hippocampal cAMP levels are temporally associated with deficits in prepulse inhibition.

Authors:  Daniel Klamer; Erik Pålsson; Kim Fejgin; Jianhua Zhang; Jörgen A Engel; Lennart Svensson
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

3.  Disruption of social approach by MK-801, amphetamine, and fluoxetine in adolescent C57BL/6J mice.

Authors:  Sheryl S Moy; Randal J Nonneman; Geoffrey O Shafer; Viktoriya D Nikolova; Natallia V Riddick; Kara L Agster; Lorinda K Baker; Darin J Knapp
Journal:  Neurotoxicol Teratol       Date:  2012-08-07       Impact factor: 3.763

4.  Glutamate receptor 6 gene (GluR6 or GRIK2) polymorphisms in the Indian population: a genetic association study on autism spectrum disorder.

Authors:  Shruti Dutta; Subha Das; Subhrangshu Guhathakurta; Barsha Sen; Swagata Sinha; Anindita Chatterjee; Sagarmoy Ghosh; Shabina Ahmed; Saurabh Ghosh; Rajamma Usha
Journal:  Cell Mol Neurobiol       Date:  2007-08-22       Impact factor: 5.046

5.  Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia.

Authors:  Tatiana Lipina; Viviane Labrie; Ina Weiner; John Roder
Journal:  Psychopharmacology (Berl)       Date:  2005-03-10       Impact factor: 4.530

6.  Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia.

Authors:  Inna Gaisler-Salomon; Gretchen M Miller; Nao Chuhma; Sooyeon Lee; Hong Zhang; Farhad Ghoddoussi; Nicole Lewandowski; Stephen Fairhurst; Yvonne Wang; Agnès Conjard-Duplany; Justine Masson; Peter Balsam; René Hen; Ottavio Arancio; Matthew P Galloway; Holly M Moore; Scott A Small; Stephen Rayport
Journal:  Neuropsychopharmacology       Date:  2009-06-10       Impact factor: 7.853

7.  Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered.

Authors:  I Gaisler-Salomon; L Diamant; C Rubin; I Weiner
Journal:  Psychopharmacology (Berl)       Date:  2007-10-11       Impact factor: 4.530

8.  Development of a mouse test for repetitive, restricted behaviors: relevance to autism.

Authors:  Sheryl S Moy; Jessica J Nadler; Michele D Poe; Randal J Nonneman; Nancy B Young; Beverly H Koller; Jacqueline N Crawley; Gary E Duncan; James W Bodfish
Journal:  Behav Brain Res       Date:  2007-11-04       Impact factor: 3.332

9.  Proteome analysis after co-administration of clozapine or haloperidol to MK-801-treated rats.

Authors:  L Paulson; P Martin; E Ljung; K Blennow; P Davidsson
Journal:  J Neural Transm (Vienna)       Date:  2007-02-22       Impact factor: 3.850

10.  A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder.

Authors:  Shahin Akhondzadeh; Hamid Tajdar; Mohammad-Reza Mohammadi; Mohammad Mohammadi; Gholam-Hossein Nouroozinejad; Omid L Shabstari; Hossein-Ali Ghelichnia
Journal:  Child Psychiatry Hum Dev       Date:  2007-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.